Study in Patients With Asthma

Completed · Phase 2

Conditions studied: Asthma

In brief

The purpose of this study is to determine which dose of the investigational drug is safest and most effective compared to the control drug.

Key facts

Study ID

NCT00215358

Run by

Dey

People needed

32

Starts

2002-07-01

Expected to finish

2005-12-01

Last updated by the study team

2010-11-11

Who can join

Age: 12 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Require regular use of an inhaled Beta-2-selective adrenergic agent

You may not qualify if…

• Active acute or chronic disorders of the respiratory system within one month prior to screening
• Smoking history within the past 12 months or greater than a lifetime 10 pack-year smoking history
• Recent surgical interventions such as lung lobectomy or resection (< one year), or cardiothoracic interventions
• Life-threatening systemic and debilitating diseases.

Where it is running

• Research Site — Denver, Colorado, United States
• Research Site — Medford, Oregon, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.